{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:26:16Z","timestamp":1791872776163,"version":"4.3.4"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002066","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uncomplicated urinary tract infections (UTIs) affect \u223c50%\u201360% of women. Treatment failure can have adverse effects on antibiotic resistance, healthcare utilization and quality of life. The lack of consistently applied definitions of treatment failure prevents comparisons between studies of UTI treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We conducted a systematic literature review to investigate definitions of treatment failure in UTI and the corresponding failure rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEDLINE, Embase and CENTRAL databases were searched from 2011 to 2024 and relevant conference proceedings from 2021 to 2024 for English language studies reporting rates of treatment failure in females aged \u226512\u2005years with uncomplicated UTI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Publications included reported 14 clinical trials, 11 non-interventional observational studies with chart review and 10 healthcare database studies. Treatment failure definitions were classified as microbiological, clinical, antibiotic prescription based or a composite of these. Evaluation timepoints typically ranged from 1 to 30\u2005days post-treatment. In clinical trials, failure rates varied from 0.8% to 83%, often with marked differences between microbiological, clinical and prescription definitions within the same trial. Rates of treatment failure using combined endpoints, including prescription failure with a healthcare encounter in database studies, were generally more consistent (6.87%\u201316.7%). Few studies assessed time to symptom resolution. Prescription failure or additional healthcare visits frequently occurred after a median 2\u20134\u2005weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Treatment failure definitions have been variably defined in the literature. Symptom scores in clinical trials and the need for additional antibiotics or healthcare visits are meaningful outcomes that could underly treatment failure definitions in future studies. The optimal time for each outcome assessment needs further evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkag112","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:49:56Z","timestamp":1774529396000},"source":"Crossref","is-referenced-by-count":3,"title":["Definitions and rates of treatment failure in females with uncomplicated urinary tract infection: a systematic literature review"],"prefix":"10.1093","volume":"81","author":[{"given":"Meghan E","family":"Luck","sequence":"first","affiliation":[{"name":"GSK , Collegeville, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Martin","sequence":"additional","affiliation":[{"name":"Evidence Synthesis, Evidera Inc. , Waltham, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Punja","sequence":"additional","affiliation":[{"name":"Evidence Synthesis, Evidera Inc. , Waltham, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kamar","sequence":"additional","affiliation":[{"name":"Evidence Synthesis, Evidera Inc. , Waltham, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priccila","family":"Zuchinali","sequence":"additional","affiliation":[{"name":"Evidence Synthesis, Evidera Inc. , Waltham, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy G","family":"Edgecomb","sequence":"additional","affiliation":[{"name":"GSK , Collegeville, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J","family":"Ellis","sequence":"additional","affiliation":[{"name":"GSK , Collegeville, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"2026041702462691000_dkag112-B1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jgar.2021.11.008","article-title":"A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance","volume":"28","author":"Wagenlehner","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"2026041702462691000_dkag112-B2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","article-title":"Urinary tract infection: self-reported incidence and associated costs","volume":"10","author":"Foxman","year":"2000","journal-title":"Ann Epidemiol"},{"key":"2026041702462691000_dkag112-B3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/14737167.2017.1359543","article-title":"Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT)","volume":"18","author":"Wagenlehner","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2026041702462691000_dkag112-B4","author":"Advani"},{"key":"2026041702462691000_dkag112-B5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2296-11-78","article-title":"Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs","volume":"11","author":"Giesen","year":"2010","journal-title":"BMC Fam Pract"},{"issue":"Suppl 3","key":"2026041702462691000_dkag112-B6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/bju.15756","article-title":"Guideline of guidelines: management of recurrent urinary tract infections in women","volume":"130","author":"Kwok","year":"2022","journal-title":"BJU Int"},{"key":"2026041702462691000_dkag112-B7","doi-asserted-by":"publisher","first-page":"ofad332","DOI":"10.1093\/ofid\/ofad332","article-title":"Definitions of urinary tract infection in current research: a systematic review","volume":"10","author":"Bilsen","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026041702462691000_dkag112-B8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/antibiotics11050627","article-title":"Variation in antibiotic treatment failure outcome definitions in randomised trials and observational studies of antibiotic prescribing strategies: a systematic review and narrative synthesis","volume":"11","author":"Neill","year":"2022","journal-title":"Antibiotics"},{"key":"2026041702462691000_dkag112-B9","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3390\/antibiotics11121846","article-title":"COSUTI: a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults","volume":"11","author":"Beecher","year":"2022","journal-title":"Antibiotics"},{"key":"2026041702462691000_dkag112-B10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13063-019-3194-x","article-title":"COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults","volume":"20","author":"Duane","year":"2019","journal-title":"Trials"},{"key":"2026041702462691000_dkag112-B11","author":"U.S. Department of Health and Human Services"},{"key":"2026041702462691000_dkag112-B12","author":"European Medicines Agency"},{"key":"2026041702462691000_dkag112-B13","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.4","author":"The Cochrane Collaboration","year":"2023"},{"key":"2026041702462691000_dkag112-B14"},{"key":"2026041702462691000_dkag112-B15","author":"Cochrane Methods Bias"},{"key":"2026041702462691000_dkag112-B16","author":"Wells"},{"key":"2026041702462691000_dkag112-B17"},{"key":"2026041702462691000_dkag112-B18","doi-asserted-by":"publisher","first-page":"e24843","DOI":"10.7759\/cureus.24843","article-title":"Efficacy of single dose of fosfomycin versus a five-day course of ciprofloxacin in patients with uncomplicated urinary tract infection","volume":"14","author":"Hassan","year":"2022","journal-title":"Cureus"},{"key":"2026041702462691000_dkag112-B19","doi-asserted-by":"publisher","first-page":"e0256464","DOI":"10.1371\/journal.pone.0256464","article-title":"Risk factors for treatment failure in women with uncomplicated lower urinary tract infection","volume":"16","author":"Martischang","year":"2021","journal-title":"PLoS ONE"},{"key":"2026041702462691000_dkag112-B20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s15010-011-0163-z","article-title":"The association of antimicrobial resistance with cure and quality of life among women with acute uncomplicated cystitis","volume":"39","author":"Abrahamian","year":"2011","journal-title":"Infection"},{"key":"2026041702462691000_dkag112-B21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s10096-015-2329-6","article-title":"Quality of life and changes in symptom relief in patients with acute uncomplicated cystitis treated with antibiotics: a prospective, open-label, multicenter, observational study","volume":"34","author":"Choi","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026041702462691000_dkag112-B22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/cid\/ciac738","article-title":"Sulopenem or ciprofloxacin for the treatment of uncomplicated urinary tract infections in women: a phase 3, randomized trial","volume":"76","author":"Dunne","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026041702462691000_dkag112-B23","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/jac\/dku014","article-title":"Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial","volume":"69","author":"Hamasuna","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2026041702462691000_dkag112-B24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/jama.2012.80","article-title":"Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial","volume":"307","author":"Hooton","year":"2012","journal-title":"JAMA"},{"key":"2026041702462691000_dkag112-B25","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1001\/jama.2018.3627","article-title":"Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial","volume":"319","author":"Huttner","year":"2018","journal-title":"JAMA"},{"key":"2026041702462691000_dkag112-B26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11655-017-2960-4","article-title":"Treatment of uncomplicated recurrent urinary tract infection with Chinese medicine formula: a randomized controlled trial","volume":"25","author":"Liu","year":"2019","journal-title":"Chin J Integrative Med"},{"key":"2026041702462691000_dkag112-B27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s10156-010-0092-2","article-title":"Clinical effects of 2 days of treatment by fosfomycin calcium for acute uncomplicated cystitis in women","volume":"17","author":"Matsumoto","year":"2011","journal-title":"J Infect Chemother"},{"key":"2026041702462691000_dkag112-B28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/apm.12147","article-title":"Mecillinam resistance and outcome of pivmecillinam treatment in uncomplicated lower urinary tract infection in women","volume":"122","author":"Monsen","year":"2014","journal-title":"Apmis"},{"key":"2026041702462691000_dkag112-B29","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.3892\/etm.2020.8970","article-title":"Combination of cranberry extract and D-mannose-possible enhancer of uropathogen sensitivity to antibiotics in acute therapy of urinary tract infections: results of a pilot study","volume":"20","author":"R\u0103dulescu","year":"2020","journal-title":"Exp Ther Med"},{"key":"2026041702462691000_dkag112-B30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/jac\/dkw424","article-title":"Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial","volume":"72","author":"Sadahira","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2026041702462691000_dkag112-B31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(23)02196-7","article-title":"Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials","volume":"403","author":"Wagenlehner","year":"2024","journal-title":"Lancet"},{"key":"2026041702462691000_dkag112-B32","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/pds.5237","article-title":"Risk of antibiotic treatment failure in premenopausal women with uncomplicated urinary tract infection","volume":"30","author":"Butler","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026041702462691000_dkag112-B33","doi-asserted-by":"publisher","first-page":"ofad500.2449","DOI":"10.1093\/ofid\/ofad500.2449","article-title":"2839. cost burden of patients with oral antibiotic treatment failure for uncomplicated urinary tract infection in the United States","volume":"10","author":"Franklin","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026041702462691000_dkag112-B34","doi-asserted-by":"publisher","first-page":"ofad500.2439","DOI":"10.1093\/ofid\/ofad500.2439","article-title":"2828. incidence of treatment failure when treated with empiric oral antibiotics among US female outpatients with uncomplicated urinary tract infection","volume":"10","author":"Fromer","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026041702462691000_dkag112-B35","doi-asserted-by":"publisher","first-page":"20499361221129415","DOI":"10.1177\/20499361221129415","article-title":"Long-term impact of fluoroquinolone-sparing strategies for empirical treatment of acute uncomplicated cystitis among ambulatory patients","volume":"9","author":"Kon","year":"2022","journal-title":"Ther Adv Infect Dis"},{"key":"2026041702462691000_dkag112-B36","author":"Patel"},{"key":"2026041702462691000_dkag112-B37","author":"Schultze"},{"key":"2026041702462691000_dkag112-B38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/biomedicines11041019","article-title":"Real-life comparison of fosfomycin to nitrofurantoin for the treatment of uncomplicated lower urinary tract infection in women","volume":"11","author":"Shafrir","year":"2023","journal-title":"Biomedicines"},{"key":"2026041702462691000_dkag112-B39","doi-asserted-by":"publisher","first-page":"S190","DOI":"10.1093\/ofid\/ofaa439.433","article-title":"123. treatment patterns and prevalence of inappropriate and suboptimal antibiotic use among females with uncomplicated urinary tract infection in the US","volume":"7","author":"Wang","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026041702462691000_dkag112-B40","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1093\/jac\/dkz350","article-title":"Effectiveness of extended-versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis","volume":"74","author":"Ten Doesschate","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2026041702462691000_dkag112-B41","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.cmi.2020.03.001","article-title":"The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function","volume":"26","author":"Ten Doesschate","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2026041702462691000_dkag112-B42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1715163518781175","article-title":"Outcomes of urinary tract infection management by pharmacists (RxOUTMAP): a study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community","volume":"151","author":"Beahm","year":"2018","journal-title":"Can Pharm J (Ott)"},{"key":"2026041702462691000_dkag112-B43","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/1060028019865224","article-title":"Evaluation of FDA boxed warning on prescribing patterns of fluoroquinolones for uncomplicated urinary tract infections","volume":"53","author":"Cowart","year":"2019","journal-title":"Ann Pharmacother"},{"key":"2026041702462691000_dkag112-B44","doi-asserted-by":"publisher","first-page":"e0280386","DOI":"10.1371\/journal.pone.0280386","article-title":"Real-world evidence: telemedicine for complicated cases of urinary tract infection","volume":"18","author":"Daumeyer","year":"2023","journal-title":"PLoS ONE"},{"key":"2026041702462691000_dkag112-B45","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jiac.2017.07.011","article-title":"Antimicrobial susceptibility of pathogens in acute uncomplicated cystitis cases in the urology department of a community hospital in Japan: comparison with treatment outcome and hospital-wide antibiogram","volume":"23","author":"Etani","year":"2017","journal-title":"J Infect Chemother"},{"key":"2026041702462691000_dkag112-B46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12894-020-00605-6","article-title":"Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study","volume":"20","author":"Koguchi","year":"2020","journal-title":"BMC Urol"},{"key":"2026041702462691000_dkag112-B47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13756-023-01282-4","article-title":"Antibiotic treatment failure of uncomplicated urinary tract infections in primary care","volume":"12","author":"Koh","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"key":"2026041702462691000_dkag112-B48","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00345-023-04303-4","article-title":"Empiric versus culture-based antibiotic therapy for UTIs in menopausal women","volume":"41","author":"Kusin","year":"2023","journal-title":"World J Urol"},{"key":"2026041702462691000_dkag112-B49","doi-asserted-by":"publisher","first-page":"12077","DOI":"10.1038\/s41598-023-38919-8","article-title":"Escherichia coli resistance, treatment patterns and clinical outcomes among females with uUTI in Germany: a retrospective physician-based chart review study","volume":"13","author":"Naber","year":"2023","journal-title":"Sci Rep"},{"key":"2026041702462691000_dkag112-B50","doi-asserted-by":"publisher","first-page":"ofad430","DOI":"10.1093\/ofid\/ofad430","article-title":"Two times versus four times daily cephalexin dosing for the treatment of uncomplicated urinary tract infections in females","volume":"10","author":"Yetsko","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026041702462691000_dkag112-B51","doi-asserted-by":"publisher","first-page":"ofab442","DOI":"10.1093\/ofid\/ofab442","article-title":"Retrospective review on the safety and efficacy of nitrofurantoin for the treatment of cystitis in the veteran population with or without renal insufficiency","volume":"8","author":"Welch","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2026041702462691000_dkag112-B52","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4111\/icu.20200240","article-title":"Single-dose amikacin plus 7 days of amoxicillin\/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing Escherichia coli: a retrospective cohort study","volume":"62","author":"Ahn","year":"2021","journal-title":"Investig Clin Urol"},{"key":"2026041702462691000_dkag112-B53","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s11606-024-09029-6","article-title":"Risk factors for empiric treatment failure in US female outpatients with uncomplicated urinary tract infection: an observational study","volume":"40","author":"Fromer","year":"2025","journal-title":"J Gen Intern Med"},{"key":"2026041702462691000_dkag112-B54","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/00365540410019642","article-title":"The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study","volume":"36","author":"Ferry","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"2026041702462691000_dkag112-B55","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/cid\/ciab749","article-title":"Envisioning future urinary tract infection diagnostics","volume":"74","author":"Patel","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026041702462691000_dkag112-B56","author":"Infectious Diseases Society of America"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/5\/dkag112\/68099040\/dkag112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/5\/dkag112\/68099040\/dkag112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:46:42Z","timestamp":1776408402000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag112\/8643945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag112","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,3]]},"article-number":"dkag112"}}